2020 Corporate Governance Survey of Hong Kong-Listed Biotech Companies

Published date01 March 2021
Subject MatterListing Rules,Hong Kong,Biotechnology,Corporate Governance,Hong Kong Stock Exchange,Hong Kong Securities and Futures Commission (HKSFC),Initial Public Offerings,HKEx,Publicly-Traded Companies
AuthorChristopher Betts,Paloma Wang
Law FirmSkadden, Arps, Slate, Meagher & Flom LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT